Levocetirizine Indications and Usage

Primary Indications

• The American Academy of Allergy, Asthma, and Immunology recommends levocetirizine for the symptomatic treatment of allergic rhinitis (both seasonal and persistent) and chronic idiopathic urticaria 1
• Levocetirizine is licensed as first-line therapy for chronic idiopathic urticaria, with well-established efficacy and safety profile, as stated by the British Association of Dermatologists 2

Mechanism and Clinical Benefits

• Levocetirizine acts exclusively as a selective antagonist of histamine H1 receptors, providing rapid onset and long duration of antihistaminic effect, according to the European Academy of Allergy and Clinical Immunology 1
• Long-term therapy (6 months) with levocetirizine reduces comorbidities including asthma in patients with persistent allergic rhinitis, as recommended by the Global Initiative for Asthma 1

Important Safety Considerations

• The American College of Obstetricians and Gynecologists advises that levocetirizine should be avoided during pregnancy, especially in the first trimester, due to limited safety data 3, 1
• The National Kidney Foundation recommends careful dose adjustment of levocetirizine in patients with renal impairment, with a required dose reduction by half in moderate renal insufficiency (creatinine clearance 10-20 mL/min) and avoidance in severe renal insufficiency (creatinine clearance <10 mL/min) 1